Navigation Links
Quintiles Central Lab, Clinical Development in China to Expand, Relocate to New Facility

RESEARCH TRIANGLE PARK, N.C., Jan. 9 /PRNewswire/ -- Quintiles Transnational Corp. today announced the expansion and consolidation of its Global Central Laboratories and Clinical Development Services (CDS) units in Beijing to accommodate their growing business in China.

The new consolidated Quintiles China facility, with more than 17,000 square feet of space, is located at Sun Dong Ann Plaza in Beijing, about one block from the previous lab site in the Peking Union Medical College Hospital (PUMCH). The new facility expands the lab space by 2,600 square feet. The lab has 13 employees and continues to add staff. CDS occupies 10,000 square feet of the combined office area, a major expansion over its old facility of under 3,000 square feet. The CDS staff strength continues to grow in Beijing and is expected to reach more than 60 people over the next 12 months.

"Quintiles' business is growing at a significant rate, and our larger facility will allow us to efficiently accommodate both the growth and our expanding test menu, which have moved well beyond basic safety testing to include specialized chemistry, PCR testing and complex flow cytometry," said Tom Wollman, Senior Vice President, Global Central Laboratories.

"We would like to thank the Peking Union Medical College Hospital for all that it has done to help Quintiles establish and expand our Central Laboratory in China," Wollman said. "PUMCH is one of the premier tertiary centers in Beijing, and we will continue to foster our close working relationship with key laboratory and scientific staff."

Lai Lee Tan, head of Clinical Operations and General Manager in China, said the consolidation of CDS and Central Lab operations in a single facility will improve coordination and efficiency for Quintiles' customers. "Our clinical development business is poised for rapid acceleration in China, and bringing our CDS and Global Labs businesses together will help our customers. The globalization of clinical research is continuing to increase, and China is just beginning to see the rapid growth we have experienced in India, Australia and throughout Asia Pacific."

Quintiles' China central lab is certified by the College of American Pathologists (CAP) and the National Glycohemoglobin Standardization Program (NGSP).

About Quintiles Global Central Laboratories

Quintiles Laboratories owns a network of clinically harmonized facilities in the U.S., Europe, South Africa, China, India and Singapore, and has tightly controlled sub-contractor laboratories in Argentina and Brazil managed by Quintiles employees located in each of the facilities.

About Quintiles

Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, financial partnering and commercialization for the pharmaceutical, biotechnology and healthcare industries. With more than 19,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry. For more information, please visit the company's Web site at .

SOURCE Quintiles Transnational Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
2. Expert Cardiologist Joins Quintiles Medical Group
3. Quintiles Names Kelly McKee Executive Director of Operations for Public Health and Government Services Unit
4. Medpace Strengthens Presence in Central Europe
5. Vet-Stem and Central Veterinary Research Labs of Dubai Sign Exclusive License
6. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
7. MyClyns(TM), a New Standard of Personal Protection, is Announced at the EMS and Firehouse Central EXPO
8. Viramontes to Lead PPD Clinical Operations in Mexico, Central America and the Caribbean
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
11. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
Post Your Comments:
(Date:10/12/2015)... ... October 12, 2015 , ... Spirax Sarco, the leader in products ... CSM-C 600 compact clean steam generator . This unit is a skid ... of HTM2031, HTM2010, and EN285 standards. The CMS-C 600 generator can produce up ...
(Date:10/12/2015)... October 12, 2015 cell surface marker ... by 2022, according to a new report by Grand View ... rise in incidence of oncology diseases and other cell-associated disorders. ... expected to reach USD 6.49 billion by 2022, according to ... in demand can be attributed to rise in incidence of ...
(Date:10/12/2015)... 12, 2015 LabStyle Innovations Corp. ... Solution, today announced its Medical Director, Dr. Moshe ... MobiHealth,s 5th EAI International Conference on Wireless Mobile ... innovations in mobile and wireless technologies," the conference will ... from October 14 - 16, 2015. The conference is ...
(Date:10/12/2015)... ... October 12, 2015 , ... NeuMedics Inc., is a ... retinal diseases that can safely and chronically be administered as an eye drop, announced ... co-hosted by The Cleveland Clinic and taking place October 25th to October 28th at ...
Breaking Biology Technology:
(Date:9/10/2015)... LONDON , Sept. 10, 2015 ... This New Study Reveals Selling Opportunities and Revenue ... What,s the future of biologics, especially new drug ... You will stay ahead with exclusive market data ... can explore trends, developments, results, opportunities and sales ...
(Date:9/10/2015)... -- Pursuant Health has collaborated with health experts ... image-based health risk assessment (HRA) optimized for Pursuant ... assessment quantifies user results into an easily understood ... biological age based on personal health habits, characteristics ... Comprised of age, gender, and risk ...
(Date:9/9/2015)... , Sept. 9, 2015  NuData Security ... and solution-based milestones, furthering the company,s commitment to ... online fraud. NuData Security,s online fraud ... the company,s growth cycle. The product combines continual ... determine good user behavior from fraudulent behavior, allowing ...
Breaking Biology News(10 mins):